What Elekta does

Elekta AB (publ) is a Swedish medical technology company founded in 1972, headquartered in Stockholm and listed on NASDAQ Stockholm (EKTA B). The company designs, manufactures, and services radiation therapy and radiosurgery systems used by hospitals, cancer treatment centers, and neurosurgery clinics in over 6,000 sites worldwide. Its portfolio spans linear accelerators (Versa HD, Harmony, Infinity, Evo), the MR-Linac system Elekta Unity that combines MRI with real-time radiation delivery, the Leksell Gamma Knife family for stereotactic intracranial radiosurgery, a brachytherapy suite (Studio, Flexitron, Oncentra, Xoft, Venezia, Geneva), and the Elekta ONE cloud-based oncology informatics platform (alongside MOSAIQ, Monaco, and Proknow analytics).

Elekta generates revenue through three primary streams: (1) capital equipment sales of treatment delivery hardware; (2) recurring software and cloud subscriptions under Elekta ONE/Elekta Axis Cloud; and (3) managed service and professional service contracts under the Elekta Care and Elekta Care 360 programs. Distribution is direct via regional offices in the Americas, Europe, Asia-Pacific, and Africa, targeting large hospital systems with an enterprise field sales motion. The customer base consists of acute care hospitals, dedicated cancer centers, radiation oncology departments, and neurosurgery centers serving oncology and neurological patients.

The company employs approximately 3,800 people globally. Recent strategic emphasis has been placed on AI-enhanced imaging (Iris technology on Elekta Evo), adaptive radiotherapy, and operational restructuring, with FY 2025/26 net sales of SEK 16,718 million (~$1.6B), adjusted EBIT margin of 12.3%, and operating cash flow of SEK 1,392 million. Mid-term targets through FY 2028/29 call for mid-single digit sales CAGR, 14–16% adjusted EBIT margin, and ~10% free cash flow conversion.

Name

Elekta

Legal name

Elekta AB (publ)

Website

https://elekta.com

Company type

Public

Founded year

1972

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Elekta AB (publ) is a Swedish medical technology company that designs and sells radiation therapy, stereotactic radiosurgery, brachytherapy, and oncology informatics systems to over 6,000 hospitals and cancer centers worldwide, generating revenue through capital equipment sales, software subscriptions, and service contracts.

Ownership category

akta.pro rank

Product category

Radiation Therapy Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

akta.pro secondary industry

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Radiation therapy systems
• Stereotactic radiosurgery
• Brachytherapy solutions
• Oncology informatics
• Linear accelerators

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Devices and Systems: Sale of radiation therapy equipment including linear accelerators, MR-Linac systems, stereotactic radiosurgery systems, and brachytherapy equipment. These are capital equipment purchases typically involving direct sales, installation, and commissioning.
2. Oncology Software Solutions: Oncology informatics software including Elekta ONE, MOSAIQ, treatment planning systems, and cloud-based services for treatment management and workflow optimization.
3. Service and Support: Elekta Care service offerings including maintenance, technical support, software updates, and training services for installed base of equipment worldwide.
4. Professional Services: Clinical training, implementation services, and consulting to support adoption and optimal use of Elekta solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Elekta designs, manufactures, and sells radiation therapy and stereotactic radiosurgery equipment, including linear accelerators (Linacs), MR-guided radiotherapy systems (Unity), Gamma Knife radiosurgery systems, brachytherapy afterloaders and applicators, and complementary oncology informatics software for treatment planning and workflow management. The company sells these solutions to hospitals, cancer treatment centers, and neurosurgery clinics worldwide, alongside related installation, training, software subscription, and ongoing service contracts.

Product overview

Elekta is a medical technology company specializing in radiation therapy, stereotactic radiosurgery, and brachytherapy solutions for cancer treatment. The product portfolio is organized around several core platforms: radiation therapy systems including linear accelerators (Versa HD, Infinity, Harmony, Evo with AI-powered Iris imaging) and MR-guided systems (Unity); stereotactic radiosurgery with the Gamma Knife platform (Esprit, Icon, Perfexion, Lightning planning optimizer, and Leksell GammaPlan software); brachytherapy solutions (Studio, ImagingRing, Oncentra Brachy, Venezia, Flexitron, Geneva, and Xoft from acquisition); oncology informatics software (MOSAIQ Plaza, Elekta ONE cloud platform, Monaco planning, Proknow analytics); neurosurgery systems (Leksell Vantage and Leksell Stereotactic System); and comprehensive services (Elekta Care, Care 360, Care Community). The company serves over 6,000 hospitals worldwide and employs approximately 3,800 people globally, with headquarters in Stockholm, Sweden.

Differentiator

Problem solved

Functional benefit

Brands

• Elekta Unity: MR-Linac system combining MRI scanner and radiation therapy for real-time tumor imaging during treatment
• Elekta Versa HD
• Elekta Harmony
• Elekta Infinity
• Elekta Evo
• Elekta Esprit
• Leksell Gamma Knife
• Leksell GammaPlan
• Elekta ONE
• MOSAIQ
• Elekta Studio
• Xoft
• Flexitron
• Oncentra Brachy

Products and services

• Elekta Unity MR-Linac system combining an advanced diagnostic MRI scanner with a radiation therapy system, enabling MRI-guided adaptive radiotherapy with real-time tumor visualization for hospitals and cancer centers.
• Elekta Versa HD Linear accelerator system for radiation therapy offering high-precision treatment delivery across multiple cancer indications including prostate, breast, and head & neck cancers.
• Elekta Harmony Linear accelerator system for radiation therapy designed for efficient and precise cancer treatment delivery.
• Elekta Infinity Linear accelerator system for advanced radiation therapy treatment with high dose rate capabilities.
• Elekta Evo CT-Linac radiation therapy system featuring AI-powered Iris imaging technology for improved tumor and organ boundary visualization during treatment.
• Elekta Esprit Stereotactic radiosurgery system for precise, non-invasive brain tumor and neurological disorder treatment with enhanced planning and workflow capabilities.
• Leksell Gamma Knife Icon Advanced stereotactic radiosurgery system with integrated imaging for intracranial treatments including brain tumors and functional disorders.
• Leksell Gamma Knife Perfexion Stereotactic radiosurgery system utilizing 192 cobalt sources for precise intracranial radiation delivery.
• Elekta ONE Cloud-based oncology informatics platform offering treatment applications, workflow management, and interoperability across radiation therapy planning and delivery, built on Microsoft Azure.
• MOSAIQ Plaza Oncology information system providing an image-enabled electronic medical record unifying diverse systems and devices across the cancer care team.
• Elekta Studio Interventional brachytherapy platform for image-guided procedures with AI-powered contouring capabilities.
• Flexitron Brachytherapy afterloader for precise radiation delivery in cancer treatment.
• Xoft Electronic brachytherapy system using a miniaturized low-energy X-ray source for various cancer treatments.
• Leksell Vantage Stereotactic System Stereotactic head frame system for neurosurgical procedures with improved design and enhanced patient comfort.
• Elekta Care Comprehensive customer service and support program offering technical support, clinical engagement, and commercial responsiveness for radiotherapy centers.
• Elekta Care 360 Full-service support package providing comprehensive coverage for Elekta equipment and software.
• Elekta Kaiku Life sciences research platform for data management and collaboration in cancer research settings.

Quantifiable outcome

• Q4 2025/26 adjusted EBIT margin of 18.9% and gross margin of 39.9% - highest of fiscal year
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Nexeva Healthcare SolutionscoreStrategic or Co-development Partner · 1 February 2026Multi-year strategic partnership for South Africa where Nexeva serves as Elekta's strategic partner to enhance technical support, clinical engagement, and commercial responsiveness for radiotherapy centers across both private and public healthcare sectors. The partnership combines Elekta's global radiotherapy innovation with Nexeva's local healthcare footprint to improve response times, strengthen local accountability, and support long-term sustainability of radiotherapy services in the region. Partnership was signed during the World Health Expo in Dubai.
• MIM Software Inc.coreTechnology or Integration · 1 April 2024Partnership to integrate vendor-neutral imaging and auto-contouring technologies into Elekta's radiation therapy planning platform. The integration aims to improve treatment precision and clinical workflows by combining MIM's imaging analytics with Elekta's treatment systems.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Varian Medical Systems (a Siemens Healthineers company): Varian is Elekta's primary direct competitor in linear accelerators (TrueBeam, Edge, Halcyon), Eclipse treatment planning, and radiosurgery. The two companies together account for the vast majority of global Linac installations, serving the same oncology centers with comparable product categories.
• Accuray: Accuray develops the CyberKnife radiosurgery system and TomoTherapy platform, directly competing with Elekta's Leksell Gamma Knife and Linac portfolio. They serve the same radiation oncology and neurosurgery customers with stereotactic and image-guided radiotherapy solutions.
• ViewRay: ViewRay developed the MRIdian system, the principal competing MR-guided radiation therapy platform to Elekta's Unity. ViewRay and Elekta Unity are the only two commercial MR-Linac systems targeting the same adaptive radiotherapy clinical use cases.
• Brainlab: Brainlab offers the ExacTrac patient positioning and radiosurgery systems, as well as surgical planning software that overlaps with Elekta's neurosurgery and radiosurgery portfolio. They compete head-to-head in intracranial and spine stereotactic radiosurgery workflows.
• RaySearch Laboratories: RaySearch develops RayStation and RayCare, treatment planning and oncology information systems that compete directly with Elekta's Monaco, Pinnacle, Elekta ONE, and MOSAIQ software. They license planning software to multiple Linac vendors including Varian and Elekta, making them a direct competitor in oncology informatics.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers owns Varian since 2021 and combines imaging, diagnostics, and now radiation therapy through its Varian subsidiary. The combined entity competes with Elekta across imaging, treatment planning, and Linacs while leveraging Siemens's global hospital relationships.
• Philips Healthcare: Philips has historically competed with Elekta in radiotherapy simulation, imaging, and treatment planning, and divested its Pinnacle TPS patent portfolio to Elekta in 2024. Philips remains a broad healthcare incumbent whose diagnostic imaging and oncology informatics offerings overlap with Elekta's portfolio in hospitals.
• GE HealthCare: GE HealthCare provides diagnostic imaging (CT, MR, PET) used in radiation oncology simulation and is a broad incumbent that competes with Elekta in hospital-based oncology imaging workflows and treatment planning adjacencies.

Emerging players

• Mevion Medical Systems: Mevion develops compact proton therapy systems (MEVION S250i) that compete with a subset of Elekta's potential addressable market in high-end radiotherapy. While Elekta does not directly sell proton systems, Mevion represents an emerging alternative modality for cancer centers considering advanced radiotherapy investment.
• RefleXion Medical: RefleXion is developing biology-guided radiotherapy (BgRT) using PET signals during treatment delivery. As an emerging technology player, RefleXion represents a potential future competitive threat to Elekta's image-guided Linac portfolio by combining functional imaging with radiation delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/elekta
• Facebookfacebook.com/Elekta
• LinkedInlinkedin.com/company/9359
• Instagraminstagram.com/elekta_

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Subsidiaries9 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A19 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elekta